Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A multidisciplinary team, comprising Andrea Chatrian, Dr Richard Colling, Professor Clare Verrill, Professor Jens Rittscher and colleagues, develops an algorithm for automated requesting of additional investigation in diagnostically uncertain prostate biopsies.

Prostate biopsy slides annotated by the AI tool with regions shaded in red (certain) or blue (ambiguous). © The Authors 2021 CC BY 4.0
Prostate biopsy slides annotated by the AI tool with regions shaded in red (certain) or blue (ambiguous).

Nearly 50,000 cases of prostate cancer are diagnosed each year in the UK. During the diagnostic process, men with suspected prostate cancer undergo a biopsy, which is analysed by pathology services. There are over 60,000 prostate biopsies performed in the UK annually, which represents a high workload for pathology teams. With increasing demand and a shortage of pathologists, tools that could help streamline this workflow would provide significant pathologist time savings and accelerate diagnoses.

To confidently diagnose prostate cancer, pathologists need to identify a number of tissue architecture and cellular cues. All biopsies are stained with Hematoxylin & Eosin (H&E), which allows the pathologist to study the size and shape (morphology) of the cells and tissue. However, in 25-50% cases, H&E staining alone does not provide sufficient evidence for a diagnosis, requiring the additional process of immunohistochemistry (IHC) to study other cellular features.

One bottleneck in the current pathology workflow is the requirement for a pathologist to review the H&E-stained biopsies to determine which require IHC. To address this need, pathologists Dr Richard Colling, Dr Lisa Browning and Professor Clare Verrill (Nuffield Department of Surgical Sciences and Oxford University Hospitals NHS Foundation Trust) teamed up with biomedical image analysts Andrea Chatrian, Professor Jens Rittscher and colleagues (Institute of Biomedical Engineering, Big Data Institute and Ludwig Oxford) to take a multidisciplinary approach.

In their paper in the journal Modern Pathologythe team used prostate biopsies annotated by pathologists at Oxford University Hospitals to train an artificial intelligence (AI) tool to detect tissue regions with ambiguous morphology and decide which cases needed IHC. The tool agreed with the pathologist’s review in 81% of cases on average. By enabling automated request of IHC based on the AI tool results, the pathologist would only need to review the case once all necessary staining had been carried out. This workflow improvement is estimated to save on average 11 minutes of pathologist time for each case, which scales up to 165 pathologist hours for 1000 prostate biopsies needing IHC.

The NHS spends £27 million on locum and private services to make up for the shortfall in pathology service provision. By using this AI tool to triage prostate biopsies for IHC, pathologists would spend less time reviewing these cases, which would not only lead to financial savings but it would also accelerate prostate cancer diagnoses to inform patients and treating clinicians earlier - Professor Clare Verrill, Nuffield Department of Surgical Sciences and Oxford University Hospitals NHS Foundation Trust 

Professor Verrill said: “The NHS spends £27 million on locum and private services to make up for the shortfall in pathology service provision. By using this AI tool to triage prostate biopsies for IHC, pathologists would spend less time reviewing these cases, which would not only lead to financial savings but it would also accelerate prostate cancer diagnoses to inform patients and treating clinicians earlier.”

The tool will now be developed and validated further using pathology data from different locations to account for variation in IHC requests between pathologist teams and centres. This future work will continue to take advantage of the PathLAKE Centre of Excellence for digital pathology and artificial intelligence, of which Oxford is a member.

This work was supported by PathLAKE via the Industrial Strategy Challenge Fund, managed and delivered by Innovate UK on behalf of UK Research and Innovation (UKRI), the NIHR Oxford Biomedical Centre, the Engineering and Physical Sciences Research Council (EPSRC), the Medical Research Council (MRC) and the Wellcome Trust.

Similar stories

EndoNET randomises first patient of 2023

A trial investigating how effective endocrine treatment is, prior to surgery in post-menopausal women with breast cancer, has randomised its first patient of the year.

New Associate Professor at NDS

The Nuffield Department of Surgical Sciences (NDS) is very happy to report that Joanna Hester has been promoted to Associate Professor.

New Cochrane review on antihistamines for motion sickness

A new systematic review from Cochrane ENT at the Nuffield Department of Surgical Sciences says antihistamines are likely to reduce the risk of developing motion sickness (travel sickness) in susceptible adults under naturally occurring conditions of movement, but they may be more likely to cause drowsiness than placebo.

Blog posts

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.